Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07851012 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiotoxicity in Newly Diagnosed Acute Myeloid Leukemia Patients

Name: Cardiotoxicity in Newly Diagnosed Acute Myeloid Leukemia Patients — clinical trial record (NCT07851012)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AML/HMA

StatusNot Yet Recruiting

PhaseNot specified

SponsorAssiut University

Started2026-10-14

View on ClinicalTrials.gov ↗

Assiut University

1,604 trials monitored

See 18 trials at risk

Leukemia

2,553 trials monitored

See 134 trials at risk

Acute Myeloid Leukemia (AML)

1,196 trials monitored

See 63 trials at risk

The aim of this study is to evaluate and compare the cardiotoxic effects associated with anthracycline-based induction chemotherapy and those receiving a Venetoclax or HMA regimens after four cycles of chemotherpy in patients with newly diagnosed acute myeloid leukemia.

Trial Details

NCT Number	NCT07851012
Lead Sponsor	Assiut University
Conditions	Newly Diagnosed Acute Myeloid Leukemia (AML)
Enrollment	146 participants
Start Date	2026-10-14
Primary Completion	2027-10-14 (estimated)
Study Completion	2028-10-14 (estimated)
Updated on ClinicalTrials.gov	2026-10-01